MB

Michael J. Bishop

DP Delta Pharmaceuticals: 6 patents #3 of 13Top 25%
FT Fimbrion Therapeutics: 4 patents #2 of 6Top 35%
GL Glaxosmithkline: 2 patents #156 of 646Top 25%
SL Smithkline Beecham Limited: 1 patents #893 of 1,624Top 55%
SL Stiefel Laboratories: 1 patents #12 of 39Top 35%
University of California: 1 patents #8,022 of 18,278Top 45%
VU Vanderbilt University: 1 patents #725 of 1,609Top 50%
GL Glaxo Group Limited: 1 patents #753 of 1,368Top 60%
KL King'S College London: 1 patents #99 of 368Top 30%
ND Novartis Vaccines And Diagnostics: 1 patents #231 of 420Top 60%
Overall (All Time): #229,845 of 4,157,543Top 6%
19
Patents All Time

Issued Patents All Time

Showing 1–19 of 19 patents

Patent #TitleCo-InventorsDate
12409177 FGFR inhibitors for the treatment of cancer Ping Cao, Chao Zhang 2025-09-09
12351597 Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of FimH James Janetka, Laurel Kathryn McGrane, Katherine L. Widdowson 2025-07-08
12297223 Compounds James Janetka, Laurel Kathryn McGrane, Eugene L. Stewart, Katherine L. Widdowson 2025-05-13
12162870 Anticancer compounds Andrew K. Shiau, Mehmet Kahraman 2024-12-10
11697665 C-mannoside compounds useful for the treatment of urinary tract infections Eugene L. Stewart, Katherine L. Widdowson, James Janetka, Laurel Kathryn McGrane 2023-07-11
11111262 C-mannoside compounds useful for the treatment of urinary tract infections Eugene L. Stewart, Katherine L. Widdowson, James Janetka, Laurel Kathryn McGrane 2021-09-07
10294214 Positive allosteric modulators of human melanocortin-4 receptor Roger D. Cone, Eugene L. Stewart, Lawrence A. Wolfe, Jaques Pantel, Julien A. Sebag +6 more 2019-05-21
9062037 Tazarotene derivatives Xue Ge, Hansen Wong, Wendy Huang Chern, Hans Hofland, Xin CAI +1 more 2015-06-23
8822518 Compounds as antagonists or inverse agonists of opioid receptors for treatment of addiction David John Cowan, Andrew Lamont Larkin, Cunyu Zhang, David Lee Musso, Gary Martin Green +3 more 2014-09-02
8633175 Compounds as antagonists or inverse agonists at opioid receptors David John Cowan, Andrew Lamont Larkin, Cunyu Zhang, David Lee Musso, Gary Martin Green +3 more 2014-01-21
7625909 Substituted quinazolinone compounds Rustum Boyce, Natalia Aurrecoechea, Daniel Chu, Aaron Smith, Christopher R. CONLEE +9 more 2009-12-01
6919350 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds Kwen-Jen Chang, Robert W. McNutt, Jr., Hugh O. Pettit 2005-07-19
6884801 Imidazoline derivatives as alpha-1A adrenoceptor ligands Eric C. Bigham, David Harold Drewry, Deanna Trojan Garrison, Stephen Joseph Hodson, Frank Navas, III +1 more 2005-04-26
6300332 Methods for reducing respiratory depression and attendant side effects of mu opioid compounds Kwen-Jen Chang, Robert W. McNutt, Jr., Hugh O. Pettit 2001-10-09
5985880 Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds Kwen-Jen Chang, Robert W. McNutt, Jr., Hugh O. Pettit 1999-11-16
5807858 Compositions and methods for reducing respiratory depression Kwen-Jen Chang, Robert W. McNutt, Jr., Hugh O. Pettit 1998-09-15
5681830 Opioid compounds Kwen-Jen Chang, Dulce Garrido Bubacz, Ann O. Davis, Robert W. McNutt, Jr., Mark A. Collins 1997-10-28
5574159 Opioid compounds and methods for making therefor Kwen-Jen Chang, Dulce Garrido Bubacz, Ann O. Davis, Robert W. McNutt, Jr. 1996-11-12
5552404 Opioid compounds and methods for using same Kwen-Jen Chang, Dulce Garrido Bubacz, Ann O. Davis, Robert W. McNutt, Jr. 1996-09-03